Pilocytic astrocytoma, pleomorphic xanthoastrocytoma, ganglioglioma, IDH-mutant gliomas, and diffuse midline glioma H3K27M-altered are included in the differential diagnoses. This evidence concerns the gene IDH1 and central nervous system cancer.